CHALLENER, C. A. (2021). Single-Use Technologies Prove Effective for Viral Vector Process Development: The benefits of single-use technologies for upstream viral-vector processes clearly outweigh their disadvantages. BioPharm International, 34(8), 12-18.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
CHALLENER, CYNTHIA A. "Single-Use Technologies Prove Effective for Viral Vector Process Development: The Benefits of Single-use Technologies for Upstream Viral-vector Processes Clearly Outweigh Their Disadvantages."
BioPharm International 34, no. 8 (2021): 12-18.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
CHALLENER, CYNTHIA A. "Single-Use Technologies Prove Effective for Viral Vector Process Development: The Benefits of Single-use Technologies for Upstream Viral-vector Processes Clearly Outweigh Their Disadvantages."
BioPharm International, vol. 34, no. 8, 2021, pp. 12-18.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.